Menicon (7780) FY2026 Q3 Earnings Report

Quick View

Executive Summary

Revenue and profit both increased, resulting in a high-quality earnings performance in which growth in Ordinary Income and Net Income particularly outpaced Operating Income. Revenue was ¥93.93B (+2.6% YoY), Operating Income was ¥9.00B (+5.0%), Ordinary Income was ¥9.47B (+15.5%), and Net Income was ¥6.35B (+24.1%). The substantial increases in Ordinary Income and Net Income were primarily attributable to the recognition of a ¥0.68B foreign exchange gain and a decline in the effective tax rate. In addition to the improvement in the core business (Operating Margin +22bp), non-operating and tax-related factors provided an additional boost.

Factors Affecting Earnings

【Revenue】Revenue was ¥93.93B, representing a +2.6% YoY increase. While the core VisionCare Business led growth with revenue of ¥87.13B (92.8% of total revenue, +3.0% YoY), Other Businesses (including Healthcare and Lifecare) reported revenue of ¥6.80B, down -2.1% YoY. The gross margin improved to 54.2% from the previous year, indicating good revenue quality.

【Profit and Loss】Operating Income was ¥9.00B (+5.0% YoY), and the Operating Margin improved to 9.6% due to gross margin improvement and restrained growth in SG&A expenses (+2.4%, below the rate of Revenue growth). However, the VisionCare Business alone saw its segment profit margin decline to 15.9% from 16.2% in the previous year, while an increase in corporate expenses (¥4.66B, +4.8%) partially restrained Operating Income growth. Ordinary Income was ¥9.47B (+15.5% YoY), substantially exceeding the growth in Operating Income, primarily due to improved non-operating income and expenses resulting from the recognition of a ¥0.68B foreign exchange gain (compared with a ¥0.04B foreign exchange loss in the previous year). Net Income was ¥6.35B (+24.1% YoY), also benefiting from a decline in the effective tax rate (approximately 2.7pt lower YoY). Overall, the company achieved higher revenue and profits, with foreign exchange and tax-related factors boosting final profit in addition to improvements at the operating level.

Segment Analysis

The VisionCare Business reported revenue of ¥87.13B (92.8% of total revenue, +3.0% YoY) and Operating Income of ¥13.88B (+1.4% YoY), with its profit margin declining to 15.9% from 16.2% in the previous year. Although revenue growth has continued, profit margins may have been somewhat pressured by raw material, logistics, and product-mix factors. Other Businesses (including Healthcare and Lifecare) reported revenue of ¥6.80B (-2.1% YoY) and continued to post a segment loss of ¥0.22B, but the loss narrowed from ¥0.67B in the previous year, indicating an improving profitability trend. Corporate expenses increased +4.8% YoY to ¥4.66B, restraining Operating Income growth as an adjustment item against total segment profit.

Key Financial Metrics

【Profitability】The Operating Margin improved to 9.6% from 9.4% in the same period of the previous year, while the Net Profit Margin increased by approximately 1.2pt to 6.8% from 5.6% in the previous year. Annualized ROE improved to 9.0% from approximately 7.9% estimated for the same period of the previous year. 【Cash Quality】Cash and deposits decreased by ¥8.35B YoY to ¥33.69B, while Property, Plant and Equipment increased +12.5% YoY to ¥93.42B, indicating continued allocation of funds to capital investment. Inventories were ¥18.05B, with inventory levels remaining relatively high. 【Investment Efficiency】Total asset turnover has remained broadly flat, and the primary driver of ROE improvement has been the increase in the Net Profit Margin. 【Financial Soundness】The Equity Ratio improved to 48.5% from 45.4% in the previous year, while financial leverage has been trending downward. The company maintains an interest-bearing debt structure that includes ¥17.35B in long-term borrowings and ¥45.00B in bonds, while retaining a conservative funding structure in which fixed liabilities exceed long-term assets.

Cash Flow Analysis

Although detailed data from the statement of cash flows was not provided, trends in the balance sheet indicate that Cash and deposits decreased by ¥8.35B YoY to ¥33.69B, while Property, Plant and Equipment increased by ¥10.36B to ¥93.42B. This suggests that the deployment of funds for capital investment, including ¥16.01B in construction in progress, placed pressure on the cash balance. Short-term borrowings increased from ¥0.025B to ¥1.85B, indicating that part of the investment funding may have been supplemented through short-term financing. The Current Ratio was 270.9%, and cash exceeded short-term liabilities by more than 18 times, indicating sufficient short-term liquidity even during a period of increased investment.

Quality of Earnings

Most of the ¥0.47B increase from Operating Income to Ordinary Income was attributable to the ¥0.68B foreign exchange gain, which represented a ¥0.73B improvement from the ¥0.04B foreign exchange loss in the previous year and has a strong temporary market-related character. Foreign exchange gains accounted for approximately 58% of ¥1.18B in non-operating income, while recurring interest and dividend income totaled only ¥0.14B. Extraordinary income and expenses resulted in a net loss of ¥0.04B due to losses on disposal of fixed assets and other items, with a limited impact on overall profit. The effective tax rate declined to 32.6% from 35.3% in the previous year, contributing to the +24.1% growth in Net Income. Comprehensive Income was ¥12.19B, substantially exceeding Net Income of ¥6.35B. The difference was attributable to ¥5.65B in foreign currency translation adjustments, primarily reflecting yen translation differences on the assets and liabilities of overseas subsidiaries, and should be distinguished from the Company’s underlying earnings power for the current period.

Earnings Forecast and Guidance

The progress rates for cumulative Q3 against the full-year Company forecasts (Revenue of ¥125.00B, Operating Income of ¥10.20B, and Ordinary Income of ¥9.50B) were 75.1%, 88.2%, and 99.6%, respectively, either exceeding or matching the standard progress rate of 75%. In particular, Ordinary Income had already reached 99.6% of the full-year forecast, and depending on additional foreign exchange effects in Q4, may exceed the full-year forecast. Meanwhile, the full-year Ordinary Income forecast assumes a -0.7% YoY decline, suggesting that the initial plan conservatively anticipated the boost from foreign exchange gains.

Shareholder Returns

The full-year forecast dividend is ¥28.00 per share, and the Payout Ratio based on forecast full-year EPS of ¥77.56 is 36.1%. The Q2 dividend was ¥0, indicating a policy of concentrating dividend payments at the fiscal year-end. Cumulative Q3 Net Income of ¥6.35B exceeds the full-year Net Income forecast of ¥5.80B, providing sufficient capacity from the perspective of securing funds for dividends. Treasury shares amounted to ¥3.11B, an increase of ¥2.18B YoY, and their trend should be monitored as a deduction from shareholders’ equity.

Risk Factors

1. Inventory Accumulation and Working Capital Efficiency: Of the ¥18.05B in Inventories, finished goods inventories accounted for ¥18.05B, indicating signs of lengthening inventory turnover days and the CCC. Given the characteristics of products such as contact lenses, there is a risk of inventory write-downs resulting from demand forecast errors or obsolescence.

2. Foreign Exchange Risk: The ¥0.68B foreign exchange gain was equivalent to 7.6% of Operating Income of ¥9.00B and made a significant contribution to growth in Ordinary Income and Net Income. As the company recorded a foreign exchange loss in the previous year, a reversal in the direction of foreign exchange movements could cause non-operating income and expenses to become a factor reducing earnings.

3. Declining Profitability in the Core Business: Against revenue growth of +3.0% in the VisionCare Business, segment profit growth was limited to +1.4%, resulting in an approximately 26bp decline in its profit margin. Including the +4.8% increase in corporate expenses, the business has a structure in which revenue growth is not being fully converted into profit growth.

Industry Benchmark (Reference; Company Analysis)

Industry Benchmark (manufacturing)

Profitability and Returns

Profitability exceeds the industry median for both metrics, representing a relatively favorable level within the industry.

Growth and Capital Efficiency

The Revenue growth rate is slightly below the industry median, positioning the company at around the industry average to somewhat modest in terms of growth speed.

※Source: Compiled by the Company

Key Takeaways from the Earnings

1. The Operating Margin improved by approximately 22bp YoY to 9.6%, and the trend of higher revenue and profits continues. However, the segment profit margin of the core VisionCare Business declined by approximately 26bp, warranting attention to the fact that revenue growth does not directly translate into profit growth.

2. The substantial increases in Ordinary Income and Net Income (+15.5% and +24.1%, respectively) were significantly supported by foreign exchange gains and the decline in the effective tax rate. The divergence from Operating Income growth (+5.0%) was attributable to factors outside the core business.

3. Progress rates against the full-year forecasts were high at 99.6% for Ordinary Income and 109.4% for Net Income. However, as these figures include factors subject to foreign exchange movements, monitoring progress on an Operating Income basis from Q4 onward will be important in assessing earnings quality.

Theoretical Stock Price (Reference Value)

Sensitivity: ¥1,129–¥1,195 at Cost of Equity ±1%, and ¥1,158–¥1,164 at ω±0.1.

Notes:

• Since Net Income progress against the full-year forecast (109%) exceeds the standard level (75%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies whose progress is ahead of schedule tend to outperform forecasts. Adjustments may be excessive for businesses with strong seasonality).
• Since forecast ROE is below the Cost of Equity, the theoretical value is below Book Value per Share.
• Net assets as of the quarter-end are used (there is a timing gap relative to the full-year forecast).
• Since net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / This is a mechanically calculated value based solely on publicly disclosed data and is not a forecast of the market price or a recommendation of any specific investment action, nor does it forecast or guarantee future stock prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility and, where necessary, after consulting with a professional advisor.

---End of Report---